Redeye comments on the CESTAFOUR and CAPAFOUR results published today.
Redeye keeps its Base Case despite cutting its 2024-2025 EBIT forecasts following a Q3 report with s...
Loihde reports its Q3 business report on October 30th.
Suominen reports Q3 results on Nov 6. The company has shown some early signs of recovery, but a lot ...
Redeye comments on Nitro Games' Q3 2024 report, which was stronger than expected, both in terms of s...
Redeye provides a more in-depth review of Episurf Medical’s Q3 report.
Gapwaves announced a supply agreement and joint development with Valeo (previously undisclosed Europ...
AVTECH delivered another stable quarter, with net sales 3% below expectations due to currency headwi...
Redeye makes slight adjustments to its forecasts following Xbrane's Q3 report, which indicated conti...
Doro delivered solid gross and operating margins in the quarter.
Ahead of Cibus' Q3 report, we include the acquisition of eight properties in Denmark and Finland, an...
Scanfil's Q3 net sales and clean EBIT were 8-9% below LSEG Data & Analytics consensus.
During Q3, Svedberg Group once again demonstrated the strength of its risk-balanced portfolio.
Redeye updates on Invisio post Q3-results which were close to our forecast while the order intake wa...
Redeye thinks that Lagercrantz reported another stable quarter in a challenging market.
Redeye retains its positive view of Sdiptech following a Q3 report that was below our estimates.
Redeye retains its positive view of Carasent following the Q3 report.
Redeye strengthens its positive view of Teneo AI following a Q3 report with substantially accelerati...
- OEM and AM challenges to normalise in Q1'25e - '24e-'26e EBIT down 18-3%; 20% CAGR '23-'26e - 30-1...
- Q3 miss driven by Thebalux seasonality - EBITA growth of 21% y-o-y - Share trading at 8x '25e EV/E...
